التفاصيل البيبلوغرافية
| العنوان: |
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial. |
| المؤلفون: |
Cefalo, Chiara M. A., Conte, Caterina, Sorice, Gian Pio, Moffa, Simona, Sun, Vinsin A., Cinti, Francesca, Salomone, Enrica, Muscogiuri, Giovanna, Brocchi, Alex A. G., Pontecorvi, Alfredo, Mezza, Teresa, Giaccari, Andrea |
| المصدر: |
Obesity (19307381); Apr2018, Vol. 26 Issue 4, p651-657, 7p |
| مصطلحات موضوعية: |
CHOLECALCIFEROL, VITAMIN D, WEIGHT loss, INSULIN resistance, DIABETES complications, DEHYDROCHOLESTEROL, THERAPEUTIC use of vitamin D, OBESITY complications, BODY composition, COMPARATIVE studies, DIETARY supplements, RESEARCH methodology, MEDICAL cooperation, RESEARCH, STATISTICAL sampling, VITAMIN D deficiency, EVALUATION research, RANDOMIZED controlled trials, BLIND experiment, DISEASE complications |
| مستخلص: |
Objective: The aim was to investigate whether vitamin D supplementation, combined with a hypocaloric diet, could have an independent effect on insulin sensitivity in subjects with both overweight and hypovitaminosis D. Changes from baseline in anthropometric parameters, body composition, glucose tolerance, and insulin secretion were considered as secondary outcomes.Methods: Eighteen volunteers who were nondiabetic and vitamin D deficient and had BMI > 25 kg/m2 were randomized (1:1) in a double-blind manner to a hypocaloric diet + either oral cholecalciferol at 25,000 IU/wk or placebo for 3 months. Hyperinsulinemic-euglycemic clamp to measure insulin sensitivity was performed at baseline and after intervention.Results: Body weight in both groups decreased significantly (-7.5% in the vitamin D group and -10% in the placebo group; P < 0.05 for both), with no between-group differences. Serum 25-hydroxyvitamin D levels in the vitamin D group increased considerably (from 36.7 ± 13.2 nmol/L to 74.8 ± 18.7 nmol/L; P < 0.001). Insulin sensitivity in the vitamin D group improved (from 4.6 ± 2.0 to 6.9 ± 3.3 mg·kg-1 ·min-1 ; P < 0.001), whereas no changes were observed in the placebo group (from 4.9 ± 1.1 to 5.1 ± 0.3 mg·kg-1 ·min-1 ; P = 0.84).Conclusions: Cholecalciferol supplementation, combined with a weight loss program, significantly improves insulin sensitivity in healthy subjects with obesity and might represent a personalized approach for insulin-resistant subjects with obesity. [ABSTRACT FROM AUTHOR] |
|
Copyright of Obesity (19307381) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder